# FDA Inspection 1267638 - Milhem, Dr Mohammed - April 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/1101142f-2e48-42a3-b030-d5ed969597c0
Source feed: FDA_Inspections

> FDA Inspection 1267638 for Milhem, Dr Mohammed on April 18, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267638
- Company Name: Milhem, Dr Mohammed
- Inspection Date: 2025-04-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1267638 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/11ae809d-9328-4dbd-bf29-d27c114c5661)
- [FDA Inspection 910676 - 2015-01-08](https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/19c3a667-b903-4af6-8394-2d8fc10e6891)
- [FDA Inspection 801722 - 2012-09-26](https://www.keypedia.com/records/fda_inspections/milhem-dr-mohammed/24afee48-635a-4f32-99f5-96ae5216dc89)

Company: https://www.keypedia.com/companies/milhem-dr-mohammed/02e6cb37-1997-4f4a-9941-d1cd67b53632

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d